Pharmaceutical companies raised prices for most medicines. Federal government policy changes then drove the reductions.

Based on key financial metrics such as the price-to-sales ratio, shareholder yield and the price-earnings ratio, the ...

The BMS-Pfizer alliance has dominated the anticoagulant drug market, earning approximately $82.6bn in revenue since 2011.

CMS has announced that the new cycle of drug price negotiations by Medicare will include big-name drugs for diabetes and HIV/AIDS, as well as Botox injections. 1,2 The 15 high-cost prescription drugs ...

The U.S. plans to negotiate the prices of 15 more medications covered by Medicare, including two of Eli Lilly's top-selling drugs - though there were few surprises. The Centers for Medicare and ...

As Gianakakos, Chief Medical Officer Edelberg and the rest of the Kardigan team continue developing their pipeline through ...

The U.S. plans to negotiate the prices of 15 more medications covered by Medicare, including two of Eli Lilly's top-selling ...

Acturis Canada has secured a key endorsement from the Center for Study of Insurance Operations (CSIO), achieving API Security ...

The U.S. government on Tuesday named the 15 new drugs targeted for Medicare price negotiations for 2028, including Gilead ...

Janux Therapeutics said on January 22 that it has partnered with Bristol-Myers Squibb Company (NYSE:BMY) to develop a new ...

Infineon’s automotive-grade MCU and companion software architecture from Munich Electrification deliver precision, safety, ...

CSIO congratulates Acturis Canada Inc. (Acturis) on achieving CSIO’s API Security Standards Certification for their Acturis ...